Covered recipient · General Payments record
JAYADEV REDDY METTU
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$2,846.23
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $774.48 | 33 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $191.44 | 11 |
| Intera Oncology, Inc | $127.80 | 1 |
| Acerta Pharma LLC | $52.47 | 2 |
| Stemline Therapeutics Inc. | $44.21 | 2 |
| Incyte Corporation | $40.39 | 2 |
| GENZYME CORPORATION | $40.34 | 2 |
| EISAI INC. | $37.85 | 2 |
| Astellas Pharma US Inc | $32.84 | 1 |
| PFIZER INC. | $30.62 | 2 |
| Daiichi Sankyo Inc. | $28.68 | 1 |
| BeiGene USA, Inc. | $27.42 | 1 |
| Mirati Therapeutics, Inc. | $23.00 | 1 |
| Genentech USA, Inc. | $21.00 | 1 |
| Gilead Sciences, Inc. | $19.16 | 1 |
| Lilly USA, LLC | $18.72 | 1 |
| SOBI, INC | $18.32 | 1 |
| GlaxoSmithKline, LLC. | $18.02 | 1 |
| Tempus AI, Inc | $15.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.35 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027760 | CMS |
| ABBVIE INC. | $5.36 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027762 | CMS |
| ABBVIE INC. | $7.93 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027764 | CMS |
| ABBVIE INC. | $34.32 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027766 | CMS |
| ABBVIE INC. | $34.21 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027768 | CMS |
| ABBVIE INC. | $4.45 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027770 | CMS |
| ABBVIE INC. | $19.64 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027772 | CMS |
| ABBVIE INC. | $26.67 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027774 | CMS |
| ABBVIE INC. | $5.45 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027776 | CMS |
| ABBVIE INC. | $21.67 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027778 | CMS |
| ABBVIE INC. | $23.39 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105027780 | CMS |
| Astellas Pharma US Inc | $32.84 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139363195 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.84 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104274247 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.63 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105664420 | CMS |
| BeiGene USA, Inc. | $27.42 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120867510 | CMS |
| Daiichi Sankyo Inc. | $28.68 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089456720 | CMS |
| Eisai Inc. | $24.50 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751490 | CMS |
| Eisai Inc. | $13.35 | 04/24/2024 | Education | Undisputed | 01/23/2026 | 1110751488 | CMS |
| Genentech USA, Inc. | $21.00 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133028531 | CMS |
| GENZYME CORPORATION | $13.46 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140003499 | CMS |
| GENZYME CORPORATION | $26.88 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140003511 | CMS |
| Gilead Sciences, Inc. | $19.16 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133799420 | CMS |
| GlaxoSmithKline, LLC. | $18.02 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116448004 | CMS |
| Incyte Corporation | $22.54 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141228404 | CMS |
| Incyte Corporation | $17.85 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141308181 | CMS |
| Intera Oncology, Inc | $127.80 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089554162 | CMS |
| Lilly USA, LLC | $18.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135033434 | CMS |
| Mirati Therapeutics, Inc. | $23.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117161051 | CMS |
| PFIZER INC. | $15.33 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131308465 | CMS |
| PFIZER INC. | $15.29 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131423798 | CMS |
| SOBI, INC | $18.32 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141417136 | CMS |
| Stemline Therapeutics Inc. | $21.20 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142960693 | CMS |
| Stemline Therapeutics Inc. | $23.01 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142960695 | CMS |
| Tempus AI, Inc | $15.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150169882 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.